---
$id: https://graph.org.ai/products/commodity/51161538
$type: Product
source: UNSPSC
code: "51161538"
title: "Eprozinol"
class: "51161500"
classTitle: "Antiasthmatic drugs"
family: "51160000"
familyTitle: "Drugs affecting the respiratory tract"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Eprozinol

**UNSPSC Code**: 51161538
**Class**: [Antiasthmatic drugs](Antiasthmatic drugs.mdx)
**Family**: [Drugs affecting the respiratory tract](../Drugs affecting the respiratory tract.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a histamine-1 receptor antagonist with the molecular formula C22H30N2O2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier IJ21AK8IVJ, chemically known as 1-piperazinepropanol, 4-(beta-methoxyphenethyl)-alpha-phenyl- but generally known as eprozinol, which bears US NIH Compound Identifier 122553. European Medicines Agency schedules Eprozinol in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06589MIG. The term EPROZINOL is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 24, No. 11 1970, List 10). World Health Organization schedules eprozinol in its Anatomical Therapeutic Chemical (ATC) Classification. EPROZINOL is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule eprozinol under HS 29335995 and SITC 51576. As of Q4 2014, EPROZINOL remains the US FDA Preferred Term for this commodity. Eprozinol bears US NLM identifiers UMLS ID C0059471 and NCI Concept Code C65522. SMILES: O(C(CN1CCN(CC1)CCC(O)C1CCCCC1)C1CCCCC1)C.

